View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
10 September, 2021updated 29 Oct 2021 11:24

Medical devices company Coloplast opens factory in Costa Rica

Denmark-based Coloplast has opened the first of two planned factories in Costa Rica to support the medical manufacturing company's global growth.

By Naomi Davies

Denmark-based Coloplast, a manufacturer of ostomy pouches and catheters, has opened a new manufacturing facility in Cartago, Costa Rica. The new site is the company’s first in Central America and will support plans to achieve an annual organic growth rate of 7–9% by 2025.

It is the first of two planned factories in Costa Rica. The second facility will become operational in the second half of 2022. The two sites represent an overall investment of more than $79.5m. Coloplast has currently created more than 200 jobs in Costa Rica and aims to have 700 staff by 2025.

Both factories will be connected to Costa Rica’s electrical power grid, which is supplied by almost 100% renewable energy. Coloplast aims to use 100% renewable energy in the manufacture of its products by 2025.

Allan Rasmussen, executive vice-president of global operations, commented: “We have chosen to establish our next factories in Costa Rica for several reasons. First, the country has qualified and highly trained labour that we can now attract. In addition, the Costa Rican authorities are very cooperative and supportive. The country also has a green electricity supply, thereby supporting our sustainability ambition. Finally, Costa Rica is close to the US, which is one of our largest growth markets.”

Coloplast is headquartered in Humlebaek, Denmark, and operates production facilities across Denmark, Hungary, China, France and the US.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Data, analysis and deep insights on foreign direct investment delivered to you
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Investment Monitor